References

• Suarez, E. A., Huybrechts, K. F., Straub, L., Hernández-Díaz, S., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B., Terplan, M., Mogun, H., & Bateman, B. T. (2022). Buprenorphine versus methadone for opioid use disorder in pregnancy. The New England Journal of Medicine, 387(22), 2033–2044. https://doi.org/10.1056/NEJMoa2203318
• Substance Abuse and Mental Health Services Administration. (2018). Medications for opioid use disorder: Treatment Improvement Protocol (TIP) series 63 (full document) (HHS Publication No. SMA 18-5063FULLDOC). https://store.samhsa.gov/product/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document/PEP21-02-01-002
• Klaman, S. L., Isaacs, K., Leopold, A., Perera, U., Hayashi, S., Vender, J., Jones, H. E., & Campopiano, M. (2017). Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: Literature review to support national guidance. Journal of Addiction Medicine, 11(3), 178–190. https://doi.org/10.1097/ADM.0000000000000308